The first stop for professional medicines advice

Specialty

267 results

Applied filters

The licence and supporting evidence for tocilizumab biosimilar

5 March 2024One licensed tocilizumab biosimilar is available: Tyenne. Learn about the licensed indications, supporting evidence and key differences.

Preparing to use tocilizumab biosimilar

5 March 2024Introducing biosimilar tocilizumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.

Options for GP practices providing influenza vaccination to staff

4 March 2024GPs can vaccinate staff using PSDs, written instructions, or via OHS or community pharmacies. Considerations for using each mechanism are explained.

Influenza vaccine written instruction templates for adoption

4 March 2024Two Influenza written instruction templates are published annually; one for NHS bodies or Local Authorities and one for independent and other providers.

Seasonal influenza vaccination and occupational health services

4 March 2024Advice on medicines mechanisms for the administration of influenza vaccinations to healthcare staff.

Using penicillin antibiotics during breastfeeding

16 February 2024All penicillin antibiotics can be used during breastfeeding with precautionary infant monitoring. Recommendations apply to full term, healthy infants.

Using benzodiazepines during breastfeeding

15 February 2024Lorazepam and oxazepam are the preferred benzodiazepines during breast feeding, if clinically appropriate. Recommendations apply to full term, healthy infants.

Using nitrofurantoin during breastfeeding

6 February 2024Nitrofurantoin can be used during breastfeeding. Recommendations apply to full term and healthy infants.

Preparing to use natalizumab biosimilar

6 February 2024Natalizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team.

Good governance when implementing natalizumab biosimilar

6 February 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.